CTC Talks: Learning - New Evidence for Treatment in KRAS‑Mutant Lung Cancer

CTC Talks: Learning - New Evidence for Treatment in KRAS‑Mutant Lung Cancer

By NHMRC Clinical Trials Centre
Online event

Overview

Can combining targeted therapy with chemotherapy and bevacizumab improve outcomes for KRAS mutant lung cancer?

This session explores how quality oversight turns ethical commitments into consistent, inspectable practice.


This presentation will cover:

  1. Why are quality systems necessary
  2. What is a Quality Management System
  3. Quality Control
  4. Quality Assurance


About the speaker:

Yael Balandrano Guerra is the Manager, Trials Integrity and Quality at the NHMRC Clinical Trials Centre. Prior to working at the CTC, Yael has held various roles across quality management and trial operations within industry.


About CTC Talks: Learning

CTC Talks: Learning (previously CTC in Learning) is an NHMRC Clinical Trials Centre (CTC) led education initiative aimed at FMH and University of Sydney staff as well as external academics and clinical research professionals. The program provides a convenient and unique forum for academics, researchers and clinical trials professionals to learn from experts in clinical trials science, methodology, and operational research.

Note: CTC Talks: Learning sessions are recorded and made publicly available on our website. By registering for this event, you consent to being recorded and to the video being shared publicly.

Category: Health, Medical

Good to know

Highlights

  • 45 minutes
  • Online

Location

Online event

Organised by

NHMRC Clinical Trials Centre

Followers

--

Events

--

Hosting

--

Free
Mar 17 · 7:00 PM PDT